The Lyme Disease Diagnostic Devices Market involves in developing and improving the devices for lyme disease diagnosis. Lyme disease is an infectious disease caused by the Borrelia and transmitted by vector ixodes scapular. It is a tick borne disease caused by the bite of infected ticks.
Symptoms of lyme disease are fever, depression, fatigue and skin rashes. In the early stage itself if the disease is diagnosed, then lyme disease treatment can be done with antibiotics. In the other case if the disease is untreated then it may affects heart, joint and central nervous system and even might become a cause for death. Lyme disease diagnostic devices are used to diagnose the patient whether he/she is having lyme disease or not. Increase in lime disease incidence throughout the world is the key growth factor for the Lyme Disease Diagnostic Devices Market.
Request For Toc @ http://www.industryarc.com/pdfdownload.php?id=7361
Scope & Regional Forecast of the Lyme Disease Diagnostic Devices Market
The increasing demand for the lyme disease diagnosis is the key growth driver for the Lyme Disease Diagnostic Devices Market. Technological advancements in diagnostic devices and increase in the number of patients suffering with the lyme disease are the primary factors that drives high growth for the market. Among all serological tests, the most often used lyme disease test is Enzyme-linked immunosorbent assay (ELISA) test. The market is being developed by introducing new diagnostic tests especially for chronic lyme disease.
As lyme disease is the most commonly reported vector-borne illness in the United States, North America accounts for the largest share of the Lyme Disease Diagnostic Devices Market. Europe is leading with the next position followed by Asia-Pacific. These two regions are expected to register high growth due to increase in patients infected with lyme diseases, during the forecast period.
Inquiry Before Purchase @ http://www.industryarc.com/inquiry-before-buying.php?id=7361
Segmentations & Key Players Involved in the Lyme Disease Diagnostic Devices Market
According to IndustryARC findings, the Lyme Disease Diagnostic Devices Market can be broken down into various segmentations on the basis of –
Diagnostic Tests: Serological Tests, Lymphocytic Transformation Test, Immunofluorescence Staining, PCR Analysis, Urine Antigen Tests and Dark Field Microscopy.
Diagnostic Technologies: Molecular Diagnostics, Brain MRI, Spinal Tap, Echocardiogram, Electrocardiogram, Monoclonal Antibodies, Flow cytometry and Gel Micro Droplets.
End Users: Hospitals / Clinics, Pharmaceutical Industries, Pathology labs and Research Institutes.
Region: Americas, Europe, Africa, Asia-Pacific and Rest of the World (RoW).
For any sales query please follow below link @ http://www.industryarc.com/support.php?id=7361
Some of the key players involved in the Lyme Disease Diagnostic Devices Market according to IndustryARC are as follows:
Abbott Laboratories
Canon U.S. Life Sciences
Fresenius Medical Care AG & Co.
Roche Diagnostics International Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.